Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Medical Devices

Medical Device Development Tools (MDDT)

                        
                Medical Device Development Tool (MDDT) Proposal Submission Content Home
          Medical Devices
          Medical Device Development Tools (MDDT)Medical Devices Medical Device Development Tools (MDDT)
  	
        Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    Print**Update: October  17, 2023**

The FDA’s Center for Devices and Radiological Health and the National Institutes of Health’s (NIH’s) National Cancer Institute are collaborating to support the small business community in developing innovative medical device development tools (MDDTs) through a new funding opportunity.

**NIH/National Cancer Institute**

Topic 460 - NIH/NCI 460 – Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies

The funding opportunity is available for small businesses through **November 14, 2023**.


Medical Device Development Tools (MDDT) Program


The FDA's Medical Device Development Tools (MDDT) program is intended to facilitate device development, timely evaluation of medical devices, and promote innovation by providing a more efficient and predictable means for collecting the necessary information to support regulatory submissions and associated decision-making.

On this page:

Why the FDA Developed the MDDT Qualification Process
	Qualified Medical Device Development Tools (MDDTs)
	MDDT Categories
	MDDT Qualification and the Qualification Process
	How to Participate in the MDDT Program
	CDRH Funding Opportunities: Small Business Innovation Research (SBIR) Grant Program
	ContactWhy the FDA Developed the MDDT Qualification Process

The MDDT program is a way for the FDA to qualify tools that medical device sponsors can choose to use in the development and evaluation of medical devices. Tools such as biomarker tests, clinician-reported outcome measures, patient-reported outcome measures, or non-clinical assessment models such as animal or computational models, and digital health technologies like sensors or wearables, play an important role in helping the FDA understand how medical devices work, in terms of safety, effectiveness, and other aspects of performance.

The voluntary MDDT program helps to improve predictability and efficiency in device development and regulatory review. When deciding whether to qualify a tool, the FDA evaluates the tool and available supporting evidence to determine whether it can be used as intended to produce scientifically plausible measurements within a specified context of use. Medical device sponsors can use qualified tools and be sure they will be accepted by the FDA without the need to reconfirm the suitability and utility of the tool within the same context of use.

Before the development of the MDDT Qualification process, the FDA evaluated tools on a case-by-case basis for each medical device submission.

The FDA created the voluntary MDDT program to:

Advance innovation, by focusing on the science needed to evaluate novel technologies.
	Increase predictability for medical device sponsors, by making it clear the FDA accepts assessments from an MDDT in support of demonstrating safety, effectiveness, or performance of a medical device, when used within the qualified context of use.
	Improve efficiency and transparency, by facilitating use of substantiated and qualified tools across multiple medical device submissions and manufacturers.
	Encourage collaboration in developing tools and supporting evidence, to pool resources and drive increased use and acceptance of qualified tools.Qualified Medical Device Development Tools (MDDTs)

The FDA has qualified MDDTs for a wide range of device types such as cardiovascular, neurology, ophthalmology, plastic surgery, automated insulin dosing, and imaging devices, as well as crosscutting tools for implanted medical devices and cybersecurity.

The following table lists MDDTs qualified by the FDA, along with a Summary of Evidence and Basis of Qualification (SEBQ) for the tool. This summary includes:

A brief description of the tool
	The qualified context of use
	A general summary of evidence to support qualification
	A brief assessment of the advantages and disadvantages of using the tool
	Information on how to contact the tool developer about accessing the toolMedical device sponsors submitting a regulatory submission that relies on a qualified MDDT can include the MDDT submission number in the cover letter or the FDA CDRH Premarket Review Submission Cover Sheet form 3514 (Section F). The MDDT submission number for each qualified tool can be found in the SEBQ.

Tool (Link to SEBQ)
			Product Area(s)
			MDDT Category
			Date QualifiedAccelerated Testing to Prove Long-Term Material Biostability
			Biostability
			Non-clinical Assessment Model
			08/09/2023Computational Tool Comprising Visible Human Project Based Anatomical Female CAD Model and Ansys HFSS/Mechanical FEM Software for Temperature Rise Prediction near an Orthopedic Femoral Nail Implant during a 1.5 T MRI Scan
			Orthopedic, MR Safety Labeling
			Non-clinical Assessment Model
			03/30/2023CHemical RISk Calculator (CHRIS) - Color Additives
			Toxicology, Biocompatibility
			Non-clinical Assessment Model
			11/28/2022FACE-Q | Aesthetics
			Plastic Surgery, Dermatology
			Clinical Outcome Assessment
			04/26/2022Virtual MRI Safety Evaluations of Medical Devices
			Imaging
			Non-clinical Assessment Model
			11/16/2021Patient-Reported Outcomes with LASIK Symptoms and Satisfaction (PROWL-SS)
			Ophthalmology
			Clinical Outcome Assessment
			06/17/2021IMAnalytics with MRIxViP1.5T/3.0T And BCLib
			Active implanted medical devices (AIMDs)
			Nonclinical Assessment Model
			05/20/2021Rubric for Applying CVSS to Medical Devices
			Cybersecurity
			Nonclinical Assessment Model
			10/20/2020BREAST-Q Reconstruction Module
			Plastic Surgery
			Clinical Outcome Assessment
			08/20/2020Insulin Dosing Systems: Perceptions, Ideas, Reflections, and Expectations (INSPIRE) Questionnaires
			Automated Insulin Dosing (AID)
			Clinical Outcome Assessment
			06/24/2020Tissue Mimicking Material (TMM) for Preclinical Acoustic Performance Characterization of High Intensity Therapeutic Ultrasound (HITU) Devices
			Imaging
			Nonclinical Assessment Model
			07/10/2019OSIRIX CDE Software Module
			Neurology
			Biomarker Test
			03/12/2019Minnesota Living with Heart Failure Questionnaire (MLHFQ)
			Cardiology
			Clinical Outcome Assessment
			03/19/2018Kansas City Cardiomyopathy Questionnaire (KCCQ)
			Cardiology
			Clinical Outcome Assessment
			10/19/2017MDDT Categories

The FDA recognizes three categories of MDDTs, which can be distinguished primarily by how the tool measures the relevant parameters:

**Non-clinical Assessment Model (NAM)** is a non-clinical test model or method that measures or predicts parameters of interest in regard to device safety, effectiveness, or device performance. For example:

	Human or animal-based models to replace clinical testing;
		*in vitro* models to replace animal testing;
		tissue and other material phantoms to evaluate imaging or other devices; and
		physics-, chemical-, or biological- based computational models.****
	**Biomarker Test (BT)** is a test or instrument used to detect or measure a biomarker. A biomarker test can be used to assess risk, or identify safety concerns, or predict treatment outcomes in patients.
	**Clinical Outcome Assessment (COA)** describes or reflects how a person feels, functions, or survives and can be reported by a health care provider, a patient, a non-clinical observer (such as a parent), or through performance of an activity or task. COAs could be collected in the clinic or remotely (e.g., collected with the use of digital health technologies). For details on COAs, see Clinical Outcome Assessments (COAs) in Medical Device Decision Making.More information about the categories of MDDT is in the final guidance, Qualification of Medical Device Development Tools.

MDDT Qualification and the Qualification Process

MDDT qualification is a conclusion that within the stated context of use, the results of an assessment that uses an MDDT can be relied upon in device evaluation and to support regulatory decision-making.

The qualification process consists of two phases: The Proposal Phase and the Qualification Phase.

Proposal Phase

The goal of the proposal phase is to determine if the MDDT is suitable for qualification through the MDDT program and to identify the performance criteria that will be used to assess qualification. In this phase, the FDA asks submitters to provide information about the tool and the data collection plan, including the context of use.

Those interested in seeking acceptance into the MDDT program should submit a complete proposal package.

For example cover letter and qualification plan contents to include in an MDDT Proposal package, see MDDT Submission Content. If you have any questions, send email to MDDT@fda.hhs.gov.

During this phase, the FDA can provide feedback to submitters on their plan to collect evidence to support qualification of the tool.

**Qualification Phase**

The goal of this phase is to determine whether, for a specific context of use, the tool is qualified based on evidence and justifications provided. In this phase, the FDA asks submitters to provide the data collected according to the qualification plan developed in the proposal phase as a full qualification package to qualify the MDDT. A submitter enters this phase after receiving notification from the FDA that the MDDT is accepted into the Qualification Program.

The Summary of Evidence and Basis of Qualification (SEBQ) is intended to present an objective and balanced summary of the scientific evidence that served as the basis of the decision to qualify an MDDT. The FDA intends to publicly disclose the SEBQ on the MDDT website if the FDA qualifies the tool.

Phase
			Goal
			Information Submitted**Proposal Phase**
			Determine if the MDDT is suitable for qualification through the MDDT program.
			Submit a complete Qualification Plan for collecting and gathering evidence for qualification of the tool, a description of the MDDT, and context of use.**Qualification Phase**
			Determine whether, for a specific context of use, the tool is qualified based on the evidence and justifications provided.
			Submit the data collected according to the Qualification Plan as part of the Full Qualification Package, which the FDA reviews for the qualification decision.For more information about the process for qualifying MDDTs, see the final guidance, Qualification of Medical Device Development Tools.

How to Participate in the MDDT Program

Any tool developer, medical device sponsor, or others, such as research organizations and academia can voluntarily submit a proposal. The program aims to provide MDDT developers and medical device sponsors with a mechanism for discussing early concepts about a tool, and facilitating increased adoption and use of qualified tools.

**Fees:**There are no fees associated with submitting a tool for qualification.

**Submitting a Proposal:** Submit an eCopy online or by mail. For cover letter and qualification plan contents to include in an MDDT Proposal, see MDDT Submission Content.

**Questions:** Email questions to MDDT@fda.hhs.gov. You may also want to refer to this webinar about the qualification of MDDT tools:

Webinar - Qualification of Medical Device Development Tools: Final Guidance – September 12, 2023CDRH Funding Opportunities to Support Small Businesses in Regulatory Science and Evidence Generation

CDRH has its own Small Business Innovation Research (SBIR) grant program. The SBIR programs encourage domestic small businesses to engage in research and development with the potential for product commercialization. These grants may be applicable to a broad variety of efforts such as development of Voluntary Consensus Standards, research methods, and Medical Device Development Tools. To determine applicability of these funding opportunities for your product, please see SBIR Omnibus/Parent Grant Solicitation *Program Description and Research Topics Document*in the SBIR/STTR Omnibus section.

The FDA defines small business as a business, including its affiliates, whose gross receipts and sales are less than $100 million for the most recent tax year.

Previous Funding Opportunities for Small Businesses Developing Medical Device Development Tools

In 2022, the FDA's Center for Devices and Radiological Health (CDRH) and the National Institutes of Health (NIH) collaborated to support the small business community in developing innovative MDDTs. Below are the funding announcements from the collaboration.

NIH/National Cancer Institute

Topic 454 – Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings

NIH/NCI 454 – Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings | NCI: SBIR & STTR (cancer.gov)NIH/National Institute of Dental Craniofacial Research

Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials

RFA-DE-23-006: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R61/R33 - Clinical Trial Not Allowed) (nih.gov)
	RFA-DE-23-007: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R42 Fast-Track - Clinical Trial Not Allowed) (nih.gov)
	RFA-DE-23-008: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track - R44 - Clinical Trial Not Allowed) (nih.gov)NIH/National Institute of Drug Abuse

Novel Drug (DDT) and Medical Device Development Tools (MDDT) for New Therapies for Substance Use Disorders (SUD)

RFA-DA-23-019: Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expediate Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) (nih.gov)
	RFA-DA-23-020: Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) (nih.gov)Contact

If you have questions about the MDDT Program, email MDDT@fda.hhs.gov.

                                                                                  Content current as of:
      10/17/2023
                  
                   
Regulated Product(s)
		 Medical DevicesMedical Device Development Tools (MDDT)                
                          

                        Medical Device Development Tool (MDDT) Proposal Submission Content
 Subscribe to CDRH New
                        Sign up to receive the daily CDRH New email update.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop